米国市場銘柄情報

RIGL リジェルファーマシューティカルズ

銘柄追加

1.220
+0.020+1.67%

終値 05/06 16:00 ET

1.240
+0.020+1.64%

市場後 17:43 ET

2.14億時価総額-8714直近PER

リジェルファーマシューティカルズに関するコメント

ログインコメントを投稿

Jenna Ragan

7 時間前

Share Your Today's Profit/Loss

Jenna Ragan

05/03 22:10

$リジェルファーマシューティカルズ(RIGL.US)$
Just needs to break that 1.22 then 2.+

Jenna Ragan

05/03 09:00

Share Your Today's Profit/Loss

Jenna Ragan

04/30 20:10

$リジェルファーマシューティカルズ(RIGL.US)$
News 📰

Trytosaveabit

04/12 20:12

Update

$リジェルファーマシューティカルズ(RIGL.US)$ Rigel Pharmaceuticals: on April 11, Entered Amendment to Credit & Security Deal of Sept 27, 2019 to Extend Maturity for Term Loans to Sept 1, 2027

Trytosaveabit

04/11 07:07

Hmm?

$リジェルファーマシューティカルズ(RIGL.US)$ Annual Report to Security Holders has been released! After doing some reading, especially the revenue increases from sales of TAVALISSE! 93.7 million versus 75.8 million in 22! And the sales of REZLIDHIA was 10.6 million versus 900K in 22! There is a lot more good stuff in the ARS! For this fact I remain bullish and happy that im swinging this! NFA!

Jenna Ragan

04/11 06:41

$リジェルファーマシューティカルズ(RIGL.US)$
Let's Go! 5.+

Jaguar8

04/11 04:34

$リジェルファーマシューティカルズ(RIGL.US)$
NEWS
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Riigel Pharmaceuticals, Inc. grants stock options to employees, including Chief Medical Officer Lisa Rojkjaer, as an inducement for employment. The options vest over four years with a one-year cliff, and additional options are tied to future performance conditions.